I am currently in a transformative leadership role at Eli Lilly and Company, where my focus is on scaling innovation through novel internal and external models. My role involves driving strategic initiatives within our Research and Development sector to significantly enhance our capabilities in delivering cutting-edge medicines. These strategic efforts are paving the way for groundbreaking advancements in our field, ensuring that our innovations not only contribute to Eli Lilly's sustained growth but also set new standards in pharmaceutical innovation.